Humoral Immunity to Vaccine-Preventable Diseases in Childhood Cancer Survivors: A Single-Center Study
Journal of Pediatric Advance Research · 23.03.2026 · 5 (1) · 1-8
DOI: 10.46889/jpar.2026.5107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pediatric Advance Research, online erschienen am 23.03.2026. Verfasst von H Benchabane und 16 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
Pediatric cancer treatments significantly impair immune memory. This study aims to evaluate the prevalence of protective vaccine-induced antibodies and characterize immune recovery in children following chemotherapy in Algeria.
Methods
A prospective study was conducted on 75 pediatric patients (median age: 6 years) in remission after cancer treatment at Mustapha University Hospital. Humoral immunity was assessed for measles, hepatitis B (HBV), diphtheria and tetanus. Cellular immunity and immunoglobulin levels were analyzed at a median of six months post-treatment.
Results
Overall, 94.6% of patients exhibited an absence of protective antibodies against at least one vaccine-preventable disease. Seronegativity rates were highest for measles (76%) and HBV (64%), followed by diphtheria (34%) and tetanus (29%). Patients with Acute Leukemia (AL) showed significantly higher rates of tetanus seronegativity compared to those with non-Hodgkin lymphoma (45.2% vs. 6.7%, p = 0.008). Immunological evaluation revealed profound CD4⁺ T-cell lymphopenia in 45% of cases. Age was significantly associated with serological status (HBV: p = 0.01; diphtheria: p = 0.04).
Conclusions
A substantial proportion of pediatric cancer survivors lose humoral immunity, particularly against measles and HBV. These findings highlight a critical window of vulnerability and strongly support the implementation of systematic post-treatment serological screening and tailored revaccination strategies.
Zitieren
APA
Benchabane, H., Boudiaf, H., Salah, S., Naamoune, S., Kechout, N., Zaabat, N., Beloufa, M., Selmani, K., Bensalem, A., Himrane, M., Ouldrouis, N., Ouldabderrahmene, N., Slimi, L., Tlidjane, N., Djemaoui, C., Nebbab, R., & Chikhi, L. (2026). Humoral Immunity to Vaccine-Preventable Diseases in Childhood Cancer Survivors: A Single-Center Study. Journal of Pediatric Advance Research, 5(1), 1-8. https://doi.org/10.46889/jpar.2026.5107
Vancouver
Benchabane H, Boudiaf H, Salah S, Naamoune S, Kechout N, Zaabat N, et al. Humoral Immunity to Vaccine-Preventable Diseases in Childhood Cancer Survivors: A Single-Center Study. Journal of Pediatric Advance Research. 2026;5(1):1-8. doi:10.46889/jpar.2026.5107
BibTeX
@article{Benchabane2026,
author = {Benchabane, H and Boudiaf, H and Salah, S and Naamoune, S and Kechout, N and Zaabat, N and Beloufa, MA and Selmani, K and Bensalem, A and Himrane, M and Ouldrouis, N and Ouldabderrahmene, N and Slimi, L and Tlidjane, N and Djemaoui, Ch and Nebbab, R and Chikhi, L},
title = {Humoral Immunity to Vaccine-Preventable Diseases in Childhood Cancer Survivors: A Single-Center Study},
journal = {Journal of Pediatric Advance Research},
year = {2026},
volume = {5},
number = {1},
pages = {1--8},
doi = {10.46889/jpar.2026.5107}
}
EUVIMED